Farallon Capital Partners, L.P. → EXELIXIS, INC. EXEL

Stake: 5.90% Shares: 15,709,500 CUSIP: 30161Q104 Class: Common Stock, par value $0.001 per share (the "Shares")

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 11.00

27,263,165 shares short · +3.5% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $37.52M

Point72 Asset Mgmt

Post-Filing Returns · since 2026-01-01 on EXEL

+1 day

0.0%

+5 days

+0.2%

+30 days

-1.8%

+60 days

-5.9%

+90 days

+1.1%

+180 days

—

Anchor price 43.58 on closest trading day on/after 2026-01-01. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on EXELIXIS, INC.

Filed	Form	Filer	Stake	Shares
2018-01-04	SC	Meditor Group Ltd	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →